Atopia Therapeutics, Formerly HpVac, Announces Appointment o

Geneva (Switzerland), May 7, 2024 – Atopia Therapeutics, a leader in the development of breakthrough asthma and allergy therapies, today announced the appointment of Dr. Grégoire Chevalier as Chief Executive

Related Keywords

France , Geneva , Genè , Switzerland , French , Jeffrey Shaw , Jacques Billy , Ludger Wess Ines Regina Buth , Innovation Center , Atopia Therapeutics , Chief Executive Officer , Board Member Jacques Billy , Ludger Wess , Business ,